Sodium Correction Formula for Hyperglycemia
For hyperglycemia, add 1.6 mEq/L to the measured serum sodium for every 100 mg/dL of glucose above 100 mg/dL to calculate the corrected sodium value. This is the standard correction endorsed by multiple diabetes guidelines 1, 2, 3, 1.
The Formula
Corrected Sodium = Measured Sodium + [1.6 × (Glucose - 100) / 100]
Where:
- Measured sodium is in mEq/L
- Glucose is in mg/dL
- The result gives corrected sodium in mEq/L
Example Calculation
If measured sodium = 130 mEq/L and glucose = 500 mg/dL:
- Corrected sodium = 130 + [1.6 × (500 - 100) / 100]
- Corrected sodium = 130 + [1.6 × 4]
- Corrected sodium = 136.4 mEq/L
Clinical Application in Hyperglycemic Crises
The corrected sodium guides fluid management decisions in diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) 1, 3, 1:
- If corrected sodium is low: Use 0.9% NaCl for fluid replacement
- If corrected sodium is normal or elevated: Use 0.45% NaCl for fluid replacement
This correction accounts for the osmotic shift of water from intracellular to extracellular compartments caused by hyperglycemia, which dilutes the measured sodium concentration 4.
Important Caveats and Limitations
The 1.6 Factor May Underestimate at Extreme Hyperglycemia
Research evidence suggests the correction factor is more complex than the guideline formula indicates:
- For glucose ≤400 mg/dL: The 1.6 factor works reasonably well 5
- For glucose >400 mg/dL: The actual sodium decrease may be closer to 4.0 mEq/L per 100 mg/dL glucose increase 5
- One study found an overall correction factor of 2.4 mEq/L per 100 mg/dL across all glucose ranges 5
However, the 1.6 correction factor remains the guideline-recommended standard for clinical practice 1, 2, 3, 1, as it provides a conservative estimate that has been validated in clinical protocols for DKA and HHS management.
Monitor Corrected Sodium During Treatment
The corrected sodium is not static—it changes during treatment due to ongoing osmotic diuresis and fluid losses 4. Recalculate the corrected sodium with each sodium and glucose measurement to guide ongoing fluid therapy decisions.
Patient-Specific Factors
The correction factor may vary based on:
- Body composition: Higher in patients with greater extracellular to total body water ratios (more adipose tissue) 6
- Renal function: Patients with stage 5 CKD have minimal osmotic diuresis, so the correction is more predictable 4
- Volume status: Extreme hypervolemia may affect the relationship 4
Corrections for Other Conditions
Hypertriglyceridemia and Hyperproteinemia
Pseudohyponatremia occurs when indirect potentiometry (used in most labs) measures falsely low sodium due to decreased serum water fraction from elevated lipids or proteins 7, 8:
- Severe hypertriglyceridemia (>1000 mg/dL): Can cause factitious hyponatremia 8
- Severe hyperproteinemia or hypoproteinemia: Alters serum water fraction and affects indirect potentiometry measurements 7
Key distinction: This is an analytical artifact, not a true change in sodium concentration. Direct potentiometry (ion-selective electrode) measures the true sodium concentration and is not affected by lipids or proteins 7.
Clinical approach: If severe hypertriglyceridemia or dysproteinemia is present with unexpected hyponatremia, request direct potentiometry measurement or recognize this as pseudohyponatremia requiring treatment of the underlying lipid/protein disorder rather than sodium replacement 8.
No Specific Formula Needed
Unlike hyperglycemia, there is no widely accepted correction formula for lipids or proteins in clinical practice. The solution is to either:
- Use direct potentiometry to measure true sodium
- Recognize and treat the underlying cause (hypertriglyceridemia, dysproteinemia)
- Avoid inappropriate sodium correction therapy for pseudohyponatremia